Subsidies & Funding

We empower medical innovation

Project Management

We manage research & innovation projects

Business Strategy

We support successful commercialisation


ERA-NET NEURON: a Joint Transnational Call (JTC) is now open

January 12 2017

NEURON (Network of European Funding for Neuroscience Research) has been established under the ERA-NET scheme of the European Commission, to promote research in the field of (disease related) neuroscience. Dutch participation in this program is through the Dutch organisation for scientific research (NWO) and the Dutch Brain Foundation (Hersenstichting).

Call for Proposals for Research Projects on "Synaptic Dysfunction in Disorders of the Central Nervous System"

The aim of the call is to facilitate multinational, collaborative research projects that will address important questions related to the synaptic dysfunction of the central nervous system. Proposals should address the disease-related synaptic dysfunction with approaches ranging from understanding basic mechanisms of disease to proof-of-concept therapeutically-driven clinical studies in humans. The ERA-NET NEURON funding organizations particularly wish to promote multi-disciplinary work and translational research proposals that combine basic and clinical approaches. Therefore, the participation of clinicians is encouraged. 

Areas of research

Research proposals should cover at least one of the following areas:

  • Fundamental research on the pathogenesis and/or aetiology of synaptopathies. This may include the development of innovative or shared resources and new technologies for prevention, diagnosis or therapy of disease.
  • Clinical research, including the exploitation of existing clinical data sets, to develop new strategies for prevention, diagnosis, and therapy for diseases in which synaptic dysfunction plays a key role.

About synaptic dysfunction

Defective synaptic communication is at the origin of numerous neurological and mental disorders synaptopathies - such as epilepsies, migraine, autism spectrum disorders, schizophrenia, mood disorders and others. The synaptopathies are often characterized by common alterations of proteins and molecular pathways affecting either neurons or glia at synapses and altering pre- and/or post-synaptic function. 

Who can apply?

Only transnational projects will be funded. Senior researchers working in universities (or other higher education institutions), non-university public research institutes, hospitals, as well as in commercial companies, particularly small and medium-size enterprises, can apply. In the Netherlands, applicants should be employed at Dutch universities or NWO- and KNAW-institutes may apply for funding and participate in a consortium, either as main applicant or as co-applicant. Senior researchers not formally affiliated with one of these research institutes can also request funding as part of a consortium. Each consortium submitting a proposal must be comprised of three to five research groups, which must be from at least three different countries

All the national funding requirements and eligibility tables are available at the ERA-NET NEURON website.

What to apply for?

The maximum amount per project that can be applied for is country-specific. In the Netherlands, the maximum amount per project is €250.000. Eligible costs are salary for a PhD student and/or Postdoctoral researcher, non-scientific personnel, material costs, travelling costs, network and consortium costs.

When to apply?

There is a two-stage application process for this call. Deadline for submission of preliminary proposals is scheduled for 14 March 2017 at 14:00 CET. Full proposals can only be submitted on explicit invitation, before June 29 2017 at 14:00 CET.


At ttopstart we are specialized in the support of competitive grant applications in the area of life sciences and we can increase your chance of success in proposals for this call. For more information please visit our funding database or contact us

Subscribe to receive up to date funding news and resources

* indicates required
Share this